Results 61 to 70 of about 4,485 (161)

Efficacy and safety of insulin lispro protamine suspension as basal supplementation in patients with type 2 diabetes

Therapeutic Advances in Endocrinology and Metabolism, 2012
The three currently marketed long-acting insulin analogs, glargine, detemir and insulin lispro protamine suspension (ILPS), represent the most significant advances in basal insulin supplementation since the 1940s and 1950s and the introduction of the ...
Dario Giugliano, Katherine Esposito
doaj   +1 more source

Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives

Сахарный диабет, 2016
In recent years there is notable growing prevalence of gestational and overt diabetes in pregnant women while rate of obstetric complications, neonatal morbidity, perinatal mortality in women with diabetes is maintained at the high level as compared with
Lyudmila A. Ruyatkina, Maksim Y. Sorokin
doaj   +1 more source

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2594-2614, April 2026.
Abstract Glucocorticoids (GCs) are widely utilised for the treatment of inflammatory and autoimmune conditions but often precipitate significant hyperglycaemia. People with type 1 diabetes (PWT1D) may be particularly affected due to the challenges of adjusting insulin dosing, for which recommendations remain unclear.
Alexandra Katz, Aidan Shulkin, Asmaa Housni, Amélie Roy‐Fleming, Rémi Rabasa‐Lhoret, Jean‐Francois Yale, Michael A. Tsoukas, Tricia M. Peters, Anne‐Sophie Brazeau   +8 more
wiley   +1 more source

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia

ClinicoEconomics and Outcomes Research, 2020
Asrul Akmal Shafie,1 Chin Hui Ng2 1Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Penang, Malaysia; 2Pharmacy Department, Hospital Raja Permaisuri Bainun, Ipoh 30450, Perak, MalaysiaCorrespondence: Asrul Akmal ...
Shafie AA, Ng CH
doaj  

Comparison of pharmacodynamics and pharmacokinetics of ultra‐rapid‐acting insulin aspart and rapid‐acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3002-3010, April 2026.
Abstract Aims To compare the effects of dose reductions of ultra‐rapid‐acting insulin aspart (URA‐IAsp) and rapid‐acting insulin aspart (IAsp) on blood glucose concentrations during continuous moderate‐intensity exercise in people with type 1 diabetes (T1D).
Jason P. Pitt, Alexander Müller, Chloe Nicholas, Olivia M. McCarthy, Othmar Moser, Stephen C. Bain, Harald Sourij, Richard M. Bracken   +7 more
wiley   +1 more source

Insulin detemir versus insulin glargine for type 2 diabetes mellitus

, 2011
Chronically elevated blood glucose levels are associated with significant morbidity and mortality. Many diabetes patients will eventually require insulin treatment to maintain good glycaemic control.
Hoekstra, Joost B., Swinnen, Sanne G., DeVries, J. Hans, Simon, Airin C. R., Holleman, Frits   +4 more
core   +1 more source

Insulin detemir and basal insulin therapy.

, 2020
With the introduction of insulin detemir (Levemir [Novo Nordisk A/S, Bagsvaerd, Denmark]), a long-acting basal insulin analog, it is an opportune moment to reevaluate the use of basal insulin therapy and consider current treatment strategies, including ...
Russell-Jones, DL
core  

Titration Algorithm for Long-acting Insulin Analog–Detemir.

, 2015
Titration Algorithm for Long-acting Insulin Analog–Detemir.
Jody Fleshman (795674), Benjamin Udoka Nwosu (476930), Lisa Greenman (795673), Louise Maranda (476925), Mary M. Lee (795677), Karen Cullen (795672), Nancy McShea (795675), Bruce A. Barton (795676)   +7 more
core   +1 more source

Análisis comparativo de insulina glargina frente a la insulina detemir: un modelo de minimización de costos aplicable en Colombia

Biomédica: revista del Instituto Nacional de Salud, 2015
Introducción. Más del 90 % de los individuos diagnosticados con diabetes mellitus presentan el tipo 2, cuya resistencia periférica a la acción de la insulina es conocida. Objetivo.
Argemiro Fragozo, María Fernanda Puerta, Juan Diego Misas   +2 more
doaj   +1 more source

Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control

, 2012
The aim of this study was to report outcomes using detemir and a protocol aimed at intensive blood glucose control with home monitoring in diabetic cats, and to compare the results with a previous study using the same protocol with glargine.
Rand, Jacquie, Roomp, Kirsten
core   +1 more source